Kalinsky, K., Lee, S., Rubin, K. M., Lawrence, D. P., Iafrarte, A. J., Borger, D. R., Margolin, K. A., Leitao, M. M., Tarhini, A. A., Koon, H. B., Pecora, A. L., Jaslowski, A. J., Cohen, G. I., Kuzel, T. M., Lao, C. D., & Kirkwood, J. M. (2017). a phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E2607). Cancer, 123(14), 2688–2697. http://access.bl.uk/ark:/81055/vdc_100047422074.0x00005f